Kunihiro Hattori
Chugai Pharma (United States)(US)The University of Osaka(JP)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Hemophilia Treatment and Research, Blood Coagulation and Thrombosis Mechanisms, Glycosylation and Glycoproteins Research, Platelet Disorders and Treatments
Most-Cited Works
- → A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model(2012)491 cited
- → Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization(2010)345 cited
- → Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity(2013)318 cited
- → Reduced elimination of IgG antibodies by engineering the variable region(2010)260 cited
- → An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors(2017)199 cited
- → Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens(2017)196 cited